Biotech Breakthrough Gets EU Approval

To read the full article, please choose one of the following options:

Pharmamar, a subsidiary of Spanish drugmaker Zeltia , has announced that its cancer drug Yondelis (trabectedin) has gained European Union (EU) approval.